Rick Doblin, Ph.D., is the founder and president of the Multidisciplinary Association for Psychedelic Studies (MAPS). His professional goal is to help develop legal contexts for the beneficial uses of psychedelics and marijuana, primarily as prescription medicines but also for personal growth for otherwise healthy people, and eventually to become a legally licensed psychedelic therapist. He founded MAPS in 1986.

MDMA-Assisted Therapy: MAPS Updates and Future Directions

Rick Doblin, Ph.D., will share updates on MAPS’ coordination of group-based MDMA-assisted therapy research, highlighting its potential for scalable, culturally responsive healing. From pilot studies to international therapist education, MAPS is developing community-centered models that prioritize access and impact. As Lykos Therapeutics focuses on U.S. regulatory approval, MAPS remains committed to advancing research, changing policy, shaping culture, and supporting healing beyond commercialization.